MedTrace Logo

Effects of Renal Replacement Therapy With Hemoadsoption in Patients With Sepsis

NCT04533256 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-09-13

No results posted yet for this study

Summary

Hemoadsorption has been demonstrated to improve clinical and paraclinical results in critically ill patients with sepsis and septic shock. The present study investigates the effects of three consecutive sessions of hemoadsorption, performed in accordance to the local protocol for treating patients with sepsis, on organ failure, severity scores and 30-days mortality. Paraclinical results and severity scores were obtained before and after the three consecutive sessions.

Conditions

Interventions

PROCEDURE

CytoSorb

three consecutive sessions of hemoadsorption in patients with sepsis

Sponsors & Collaborators

  • Institutul Clinic Fundeni

    lead OTHER

Principal Investigators

  • Dana Tomescu, Prof · Fundeni Clinical Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-10
Primary Completion
2021-07-30
Completion
2021-07-30

Countries

  • Romania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04533256 on ClinicalTrials.gov